文献速递免疫规划传染病防控与疫情报告

澳大利亚男同性恋、双性恋男性及非二元性别者中的猴痘疫苗接种覆盖率:2024年初行为学监测结果

Mpox vaccination coverage among Australian gay and bisexual men and non-binary people: Results of behavioural surveillance in early 2024.
PubMed 文献 · Vaccine · 2025-03-17

研究利用2024年澳大利亚三个司法辖区对男同性恋、双性恋、酷儿及其他男男性行为者及非二元性别者(GBQ+人群)的横断面调查,评估猴痘疫苗接种率及相关因素。在4252名参与者中,46.2%未接种,12.3%接种一剂,41.5%接种两剂。社会与临床参与度高的男同性恋者更可能接种,而年轻、双性恋、亚洲或拉丁美洲出生及居住在非内城区者接种率较低。作者建议针对性信息与外展以提高接种。

要点

  • 2024年初澳大利亚GBQ+人群中46.2%未接种猴痘疫苗,41.5%完成两剂接种。
  • 任何接种与年龄>30岁、大学教育、有伴侣、GBQ+社交参与度高、使用PrEP或HIV阳性、近期HIV检测、近期衣原体诊断、多个性伴及在性场所或海外结识性伴相关。
  • 未接种与双性恋(vs男同性恋)、亚洲或拉丁美洲出生(vs澳大利亚)、居住在外都市或偏远地区(vs内都市)相关。

核心结论

  • 社会与临床参与度高的男同性恋者更可能接种猴痘疫苗,而年轻、双性恋、亚洲和拉丁美洲出生及居住在内城区以外者接种可能性较低。
  • 作者建议针对性信息与外展以提高接种率,面向较少使用性健康服务和GBQ+社交参与度较低的人群。

研究设计与样本

  • 横断面调查,于2024年在澳大利亚首都领地、新南威尔士州和维多利亚州对GBQ+人群进行行为学监测。
  • 纳入性活跃且未诊断猴痘的参与者,共4252人。
  • 采用多变量logistic回归分析:(1)未接种 vs 部分/完全接种;(2)部分 vs 完全接种。

主要发现

  • 4252名参与者中,46.2%未接种,12.3%接种一剂,41.5%接种两剂。
  • 任何接种与以下因素相关:年龄>30岁、大学教育、有伴侣、GBQ+社交参与度较高、使用PrEP或HIV感染者(vs HIV阴性非PrEP使用者)、过去一年内检测HIV(vs >12个月前)、≤12个月内诊断衣原体、近期性伴2-10个或>10个(vs 1个)、在性场所和海外结识性伴。
  • 未接种与以下因素相关:双性恋(vs 男同性恋)、亚洲或拉丁美洲出生(vs 澳大利亚)、居住在外都市或偏远地区(vs 内都市)。
  • 与部分接种相比,完全接种与以下因素相关:年龄>30岁、跨性别男性(vs 顺性别男性)、大学教育、近期性伴>10个(vs 1个)。

临床怎么用

  • 作者建议针对性信息与外展,以提高较少使用性健康服务及GBQ+社交参与度较低人群的疫苗接种率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We examined characteristics associated with mpox vaccine uptake among gay, bisexual, queer and other men who have sex with men and non-binary people (GBQ+ people), the primary target group for Australian vaccination programs following the mid-2022 outbreak. METHODS: Vaccine uptake was assessed using cross-sectional surveys of GBQ+ people from three Australian jurisdictions in 2024: Australian Capital Territory, New South Wales, and Victoria. Sexually active, mpox-undiagnosed participants were included. Multivariable logistic regression examined: (1) no vaccination vs. partial/full vaccination, and (2) partial vs. full vaccination. RESULTS: Among 4252 participants, 46.2 % were unvaccinated, 12.3 % had received one vaccine dose, and 41.5 % had received two doses. Any vaccination was associated with: being >30 years old, being university-educated, being in a relationship, greater GBQ+ social engagement, being a PrEP user or person living with HIV vs. an HIV-negative non-PrEP-user, testing for HIV in the last year vs. >12 months ago, being diagnosed with chlamydia ≤12 months ago, having 2-10 recent sexual partners or > 10 partners vs. one recent partner, and meeting sex partners at sex venues and overseas. No vaccination was associated with: being bisexual vs. gay, being born in Asia or Latin America vs. Australia, and living in outer metropolitan or regional/remote areas vs. inner metropolitan areas. Compared to partial vaccination, full vaccination was associated with: being >30 years old, being a transgender vs. cisgender man, being university educated, and having >10 recent sexual partners vs. one. CONCLUSIONS: Socially and clinically engaged gay men were more likely to be vaccinated against mpox. Younger participants, bisexual participants, those born in Asia and Latin America, and those living outside inner metropolitan areas were less likely to be vaccinated. We recommend targeted messaging and outreach to increase vaccination among people who attend sexual health services less frequently and those less socially engaged with QBQ+ people.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. MacGibbon J, Storer D, Bavinton BR, et al. Mpox vaccination coverage among Australian gay and bisexual men and non-binary people: Results of behavioural surveillance in early 2024. Vaccine. 2025. PMID: 40101325. doi:10.1016/j.vaccine.2025.127014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。